Cargando…

WCN23-0275 EFFECT OF HEMOPERFUSION ON THE CLINICAL OUTCOME OF SEVERE AND CRITICAL COVID-19 PATIENTS ADMITTED AT THE UNIVERSITY OF SANTO TOMAS HOSPITAL: AN ANALYTICAL COHORT STUDY

Detalles Bibliográficos
Autores principales:	UMLAS, C.A., Pe, D.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Covid-19 and AKI
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025603/ http://dx.doi.org/10.1016/j.ekir.2023.02.974

Ejemplares similares

WCN23-0229 CLINICAL OUTCOMES OF HEMOPERFUSION USING HA330 FILTER AMONG PATIENTS WITH SEVERE AND CRITICAL COVID-19 AT THE UNIVERSITY OF SANTO TOMAS HOSPITAL: A ONE-YEAR RETROSPECTIVE STUDY
por: DIZON, J.M., et al.
Publicado: (2023)

WCN23-0553 THE RELATIONSHIP OF HYPONATREMIA WITH IL-6 AND IMPLICATIONS ON CLINICAL OUTCOMES IN COVID-19 PATIENTS ADMITTED AT UNIVERSITY SANTO TOMAS HOSPITAL, JANUARY TO AUGUST 2021
por: PEÑA, M.R., et al.
Publicado: (2023)

POS-033 Effect of Hemoperfusion on the Clinical Outcome of Severe and Critical COVID-19 patients admitted at the University of Santo Tomas Hospital: An Analytical Cohort Study
por: Umlas, C.A., et al.
Publicado: (2022)

WCN23-0333 THE FREQUENCY OF DYSNATREMIA IN PATIENTS ADMITTED WITH COVID-19 INFECTION
por: KHAN, F.G., et al.
Publicado: (2023)

WCN23-0624 ACUTE KIDNEY INJURY AND COVID-19
por: JERNDAL, H., et al.
Publicado: (2023)

WCN23-0316 COVID-19 VACCINATION INDUCED MINIMAL CHANGED DISEASE
por: ALKANDARI, N., et al.
Publicado: (2023)

WCN23-1131 RISK OF AKI IN COVID-19 PATIENTS: CLINICAL COURSE AND OUTCOMES
por: Flores Fonseca MD, M.M., et al.
Publicado: (2023)

WCN23-0098 SERUM SODIUM AS A PREDICTOR OF MORBIDITY AND MORTALITY IN COVID-19 PATIENTS ADMITTED TO THE UNIVERSITY HOSPITAL OF THE WEST INDIES BETWEEN AUGUST 2020-JANUARY 2021
por: NG, W.Y., et al.
Publicado: (2023)

WCN23-1216 KIDNEY BIOPSIES DURING THE COVID-19 OUTBREAK: A SERIES OF CASES
por: Pantaleon, H., et al.
Publicado: (2023)

WCN23-0328 ASSOCIATION OF DYSNATREMIA WITH MORBIDITY AND MORTALITY OF COVID-19 PATIENTS ADMITTED IN THE INTENSIVE CARE UNITS OF A TERTIARY CARE HOSPITAL: A RETROSPECTIVE COHORT STUDY
por: ZACARIAS, M.C., et al.
Publicado: (2023)

WCN23-1161 LONG-TERM EVOLUTION OF KIDNEY FUNCTION OF COVID-19 SURVIVORS WHO WERE HOSPITALIZED AND DID OR DID NOT DEVELOP ACUTE KIDNEY INJURY
por: BECERRA GUTIERREZ, C.A., et al.
Publicado: (2023)

WCN23-0317 AKI IN HOSPITALIZED COVID-19 PATIENTS- AN EPIDEMIOLOGY STUDY IN A TERTIARY CENTER
por: OOI, S., et al.
Publicado: (2023)

WCN23-0213 PROXIMAL TUBULAR DYSFUNCTION AS A PREDICTOR OF AKI IN HOSPITALIZED COVID-19 PATIENTS
por: ALIMUL BARI, A., et al.
Publicado: (2023)

WCN23-0071 CYTOKINE ADSORBING COLUMN IN SEVERE COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY
por: Madhyastha, P., et al.
Publicado: (2023)

WCN23-0857 Utility of urinary biomarkers for diagnosis of acute kidney injury (AKI) in COVID-19
por: SAMRA, T., et al.
Publicado: (2023)

WCN23-1046 PATHOGENETIC ASPECTS OF THE DEVELOPMENT OF ACUTE KIDNEY INJURY IN COVID 19: OWN OBSERVATION DATA
por: GARAZHAYEVA, L., et al.
Publicado: (2023)

WCN23-0359 RENAL FLARE IN ADOLESCENTS WITH LUPUS NEPHRITIS RECEIVED COVID-19 mRNA VACCINE
por: THEPVEERA, S., et al.
Publicado: (2023)

WCN23-0357 Quercetin potentially suppresses renal fibrosis in patients with COVID-19 under hypoxic state
por: GUO, J., et al.
Publicado: (2023)

WCN23-0208 THE PREVALENCE AND SHORT-TERM OUTCOMES OF ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19 INFECTION
por: OGANGA, M., et al.
Publicado: (2023)

WCN23-0637 CLINICAL PROFILE AND OUTCOMES OF COVID-19 IN RENAL TRANSPLANT RECIPIENTS – A SINGLE CENTRE EXPERIENCE
por: ANAGHASHREE, U., et al.
Publicado: (2023)

WCN23-1032 CHARACTERISTICS OF ACUTE KIDNEY INJURY IN COVID-19 ADULT PATIENTS IN A SINGLE CENTER IN INDONESIA
por: Muzasti, R., et al.
Publicado: (2023)

WCN23-0312 THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR AND OTHER URINARY CYTOKINES SINCE SUBCLINICAL AKI IN PATIENTS WITH COVID-19
por: CASAS, G., et al.
Publicado: (2023)

WCN23-0017 A CASE REPORT OF ‘RETROPERITONEAL FIBROSIS CAUSING RENOVASCULAR HYPERTENSION’ ASSOCIATED WITH SARS-CoV2
por: Cheema, S., et al.
Publicado: (2023)

WCN23-0874 A CROSS-SECTIONAL STUDY OF THE PREVALENCE AND OUTCOMES OF ACUTE KIDNEY INJURY IN PATIENTS WITH COVID 19 AT A TERTIARY HOSPITAL IN NAIROBI
por: Cheruiyot, S., et al.
Publicado: (2023)

WCN23-0461 PATTERNS OF RECOVERY OF KIDNEY FUNCTION IN PATIENTS WITH COVID-19 AND ACUTE KIDNEY INJURY IN A REFERENCE CENTER IN MEXICO
por: REAL, F., et al.
Publicado: (2023)

WCN23-0230 Life Threatening Spontaneous Hematoma in Unusual sites in patient with Covid-19 on Anticoagulant Therapy (4 case reports)
por: SAMAD, M., et al.
Publicado: (2023)

WCN23-0183 ACUTE KINDEY INJURY OVER EXISTING CHRONIC KIDNEY DISEASE IN PATIENTS WITH SARS-CoV-2 INFECTION
por: FILEV, R., et al.
Publicado: (2023)

WCN23-0657 ADMISSION HEMOGLOBIN AS A PROGNOSTIC FACTOR FOR MAJOR ADVERSE KIDNEY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 AND ACUTE KIDNEY INJURY
por: KORTRIGHT MALDONADO, K.M., et al.
Publicado: (2023)

WCN23-0295 INCIDENCE AND RISK FACTORS OF ACUTE KIDNEY INJURY IN PATIENTS WITH SEVERE COVID-19 INFECTION IN TERTIARY CARE HOSPITAL IN THAILAND
por: ANUMAS, S., et al.
Publicado: (2023)

WCN23-0548 Association of urinary mitochondrial DNA with COVID-19 related acute kidney injury, mitochondrial stress, and inflammation in renal transplant recipients
por: Prasad, N., et al.
Publicado: (2023)

WCN23-1022 Persistent microscopic hematuria in IgA nephropathy and frequency of gross hematuria following SARS-CoV-2 mRNA vaccination
por: YOKOTE, S., et al.
Publicado: (2023)

WCN23-0262 CLINICAL CHARACTERISTICS AND RISK FACTORS ASSOCIATED WITH ACUTE KIDNEY INJURY AMONG HOSPITALIZED PRIMARY COVID-19 INFECTED PATIENTS, SINGLE CENTER EXPERIENCE
por: CHAIKOMON, K., et al.
Publicado: (2023)

WCN23-1160 INCIDENCE, RISK FACTORS AND OUTCOME OF ACUTE KIDNEY INJURY (AKI) IN COVID-19 PATIENTS IN A SUB-SAHARAN AFRICAN INTENSIVE CARE UNIT: A PROSPECTIVE COHORT STUDY
por: Nlandu Mayamba, Y., et al.
Publicado: (2023)

WCN23-0981 RISK FACTORS FOR COVID-19 MORTALITY IN HEMODIALYSIS PATIENTS
por: TOMANOSKI, V., et al.
Publicado: (2023)

WCN23-0430 PREDICTORS FOR FAILURE REDUCTION OF HEMODIALYSIS FREQUENCY DURING THE PANDEMIC
por: Pattharanitima, P., et al.
Publicado: (2023)

WCN23-0345 EFFECTIVENESS OF COVID-19 VACCINE IN PATIENT UNDERGOING HEMODIALYSIS
por: FATIMAH, S., et al.
Publicado: (2023)

POS-032 CLINICAL OUTCOMES OF HEMOPERFUSION USING HA330 FILTER AMONG PATIENTS WITH SEVERE AND CRITICAL COVID-19 AT THE UNIVERSITY OF SANTO TOMAS HOSPITAL: A ONE-YEAR RETROSPECTIVE STUDY
por: Dizon, J.M., et al.
Publicado: (2022)

WCN23-0651 LONG-TERM EFFECTIVENESS OF COVID-19 VACCINE AMONG DIALYSIS PATIENTS
por: Rosa Diez, G., et al.
Publicado: (2023)

WCN23-0825 TELENEPHROLOGY: MANAGING CHRONIC KIDNEY DISEASE DURING COVID-19 PANDEMIC
por: Sharma, S.K., et al.
Publicado: (2023)

WCN23-1238 COMORBIDITIES ASSOCIATED WITH INCREASED RISK OF DEATH IN CKD PATIENTS WITH COVID-19
por: BRAZ, B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9g2bjpgu8jgi5f6mj2hjvk1fus